Low dose Naltrexone for induction of remission in inflammatory bowel disease patients

BACKGROUND: Around 30% of patients with inflammatory bowel disease (IBD) are refractory to current IBD drugs or relapse over time. Novel treatments are called for, and low dose Naltrexone (LDN) may provide a safe, easily accessible alternative treatment option for these patients. We investigated the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Transl Med
Main Authors: Lie, Mitchell R. K. L., van der Giessen, Janine, Fuhler, Gwenny M., de Lima, Alison, Peppelenbosch, Maikel P., van der Ent, Cokkie, van der Woude, C. Janneke
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5845217/
https://ncbi.nlm.nih.gov/pubmed/29523156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1427-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados